
Journal of Organic Chemistry p. 69 - 76 (1985)
Update date:2022-08-04
Topics:
Muskopf, Jack W.
Coates, Robert M.
The pyrrolidine-induced aldol cyclization of methyl 2-methyl-2-(3-oxobutyl)-1,3-dioxocyclohexane-4-acetate (1) afforded methyl 1,2,3,4,6,7,8,8a-octahydro-8a-methyl-1,6-dioxonaphthalene-2-acetate (13) rather than undergoing lactonization-directed closure in the opposite sense.Mild base-induced cyclization of 1 with sodium methoxide in methanol or 1,8-diazabicyclo<5.4.0>undec-7-ene (DBU) in tetrahydrofuran (THF) effected cleavage of the cyclohexane-1,3-dione ring, giving mainly cyclohexenone acid 14a (2-(1,4-dimethyl-3-oxo-1-cyclohexen-2-ylmethyl)butanedioic acid monomethyl ester) and δ-lactone 15 (methyl (4aβ,8aβ)-octahydro-6,8a-dimethyl-2,5-dioxo-2H-1-benzopyran-4a-acetate).Prolonged exposure of 15 to sodium methoxide in methanol yielded mixtures of acyclic diester 17 and the isomeric γ-lactone 18 presumably via lactone methanolysis to ketol diester 16 followed by retroaldol ring opening or relactonization onto the acetate ester.The structure and stereochemistry of 18 were established by X-ray crystallography (Figure 1).Similar aldol cyclizations of 2-methyl-2-(3-oxobutyl)-1,3-cyclohexanedione (19) and its 4-methyl analogue (11) with sodium methoxide in methanol or DBU in THF afforded cyclohexenone acids 20a and 22a, respectively, the latter accompanied by δ-lactone 23.Bridged ketols 21 (from 19) and 24 and 25 (from 11) were also isolated from the reactions with DBU.A novel mechanism (Scheme I) involving bridging aldol cyclization to endo ketols (27 and 30), intramolecular hemiketal formation to oxatwistanones (28 and 31), ring cleavage to δ-lactones (29 and 32), and β-elimination of the δ-lactones having an available α-hydrogen to cyclohexenone acids is proposed to explain the formal retro-Claisen transformations in the absence of an external nucleophile (DBU/THF) and the apparent hydrolyses under anhydrous conditions.
View MoreJiaxing Anrui Material Technology Co., Ltd.
Contact:86-573-82651652 13305832579
Address:Room 407, Technology Building, 1369 Chennan Road, Jiaxing City, Zhejiang, China
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Wuxi D-Stone International Co., Ltd.
Contact:+86-510-82740567
Address:21F Hengtong Int'l Centre, 215Zhongshan Road, Wuxi, Jiangsu,China
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Doi:10.1021/jm00222a004
(1977)Doi:10.1016/S0040-4020(01)82727-7
(1969)Doi:10.1021/jm070415w
(2007)Doi:10.1002/jlcr.2590070210
(1971)Doi:10.1007/BF01880945
()Doi:10.1016/S0040-4039(01)85317-X
(1978)